NASDAQ:EVGN

Biotechnology·Finance·NASDAQ:EVGN·News·Stock Market

Evogene Back Under $1 as Nasdaq Deadline Approaches

Evogene shares fell 3.5% to $0.69 Friday, staying below Nasdaq’s $1 minimum and risking delisting if not fixed by Sept. 28. First-quarter revenue dropped to $334,000 from $2.34 million last year, with net loss widening to $5.9 million. The company is cutting non-core businesses and seeking strategic deals, but CEO Ofer Haviv said big pharma partnerships will take time.

May 29, 2026

Can British American Tobacco's 5.3% Dividend Yield Sustain Amid Market Challenges?
May 29, 2026, 11:29 AM EDT. British American Tobacco (BATS) offers a 5.3% dividend yield, exceeding the FTSE 100 average of 3%, and has a record of decades-long annual dividend growth, reflecting its strong cash generation. This is supported by its premium brand portfolio and low production costs in the tobacco industry. However, declining cigarette volumes over the past two years present a risk, as global cigarette consumption falls. The company aims to counteract these trends by increasing prices and expanding into non-cigarette products like vapes. Despite these efforts, investors face challenges including ethical concerns and uncertainty about the long-term profitability of new product lines. The future sustainability of its dividend depends on navigating these market headwinds and evolving consumer preferences.